Background We initiated a pancreatic islet transplantation program using fr
esh, single-donor tissue.
Methods. Group 1 (n=3) received cadaver kidney and islets from the same don
or; islets were placed beneath the capsule of the transplanted kidney. Grou
p 2 (n=6) received islets via percutaneous portal vein puncture subsequent
to successful kidney transplant. Group I and 2 recipients had type 1 diabet
es mellitus. Group 3 (n=6) received autologous islet transplantation after
total or near-total pancreatectomy (for chronic pancreatitis and intractabl
e pain). Implantation and graft function was considered successful if C-pep
tide exceeded 0.10 ng/ml. Sustacal challenge test was done before and after
transplant at day 1, week 1, and months 1, 3, 6, and 12. We also measured
glycated. hemoglobin and insulin requirements at regular time intervals.
Results. Post-Ficoll yield was 402,000 (SD 174,000) equivalent islet number
, average purity of 67% (range, 50-90%). Group 1 had initial primary nonfun
ction followed by occasional evidence of C-peptide at months 3 and 6. Group
2 recipients had significant C-peptide levels early after transplantation
which gradually declined over several months. However, all recipients had g
raft function at 6 months and 50% recipients still maintained graft functio
n at 1 year. Group 8 recipients are off exogenous insulin (mean follow-up o
f 5.5 months). Insulin requirement was unchanged in group 1, while a reduct
ion of approximately 20% was noted in four of six patients in group 2. Glyc
ated hemoglobin was reduced in four out of six recipients of group 2, while
in group 3, glycated hemoglobin remained within normal limits. Pain relief
was sustained when patients (group 3) received total pancreatectomy; near-
total pancreatectomy resulted in recurrence of pain within 3 months.
Conclusions. Autologous islet transplantation is uniformly successful; tota
l excision of pancreas was superior to partial pancreatectomy for pain reli
ef. For allogeneic islet transplantation, the intrahepatic site is superior
to the renal subcapsular site. Insulin independence was not achieved in al
logeneic islet transplants; however, continued graft function resulted in r
eduction of glycated hemoglobin in some recipients.